UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy

International journal of STD & AIDS, 2005-01, Vol.16 (1), p.38-41

2005

Volltextzugriff (PDF)

The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda

AIDS and behavior, 2006-07, Vol.10 (4), p.437-442

2006

Volltextzugriff (PDF)

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

AIDS (London), 2007-05, Vol.21 (8), p.965-971

2007

Volltextzugriff (PDF)

Difficulties in the prevention, diagnosis, and treatment of imported malaria

Archives of internal medicine (1960), 2000-09, Vol.160 (16), p.2505

2000

Volltextzugriff (PDF)

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting

Journal of acquired immune deficiency syndromes (1999), 2004-08, Vol.36 (5), p.1100-1102

2004

Volltextzugriff (PDF)

Identification of preferential CD4+ T-cell targets for HIV infection in the cervix

Mucosal immunology, 2016-01, Vol.9 (1), p.1-12

2016

Volltextzugriff (PDF)

IDF21-0662 Diabetes CarePak: Creating & testing a bundling solution to improve access to safe insulin administration in Kenya

Diabetes research and clinical practice, 2022-04, Vol.186, p.109387, Article 109387

2022

Volltextzugriff (PDF)

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial

PLoS medicine, 2012-05, Vol.9 (5), p.e1001217

2012

Volltextzugriff (PDF)

Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda

AIDS research and human retroviruses, 2014-09, Vol.30 (9), p.896

2014

Volltextzugriff (PDF)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

Clinical infectious diseases, 2012-12, Vol.55 (12), p.1707-1718

2012

Volltextzugriff (PDF)

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

The Journal of clinical investigation, 1998-11, Vol.102 (9), p.1758-1765

1998

Volltextzugriff (PDF)

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda

Human resources for health, 2009-08, Vol.7 (1), p.76-76, Article 76

2009

Volltextzugriff (PDF)

Prevalence and Virologic Consequences of Transmitted HIV-1 Drug Resistance in Uganda

AIDS research and human retroviruses, 2014-09, Vol.30 (9), p.896-906

2014

Volltextzugriff (PDF)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

PloS one, 2012-04, Vol.7 (4), p.e33672

2012

Volltextzugriff (PDF)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

PloS one, 2014-03, Vol.9 (3), p.e90772

2014

Volltextzugriff (PDF)

Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μl

AIDS (London), 2008-01, Vol.22 (2), p.237-247

Anon

2008

Volltextzugriff (PDF)

Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring

Journal of acquired immune deficiency syndromes (1999), 2010-10, Vol.55 (2), p.277-283

2010

Volltextzugriff (PDF)

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART

BMC infectious diseases, 2013-08, Vol.13 (1), p.395-395, Article 395

2013

Volltextzugriff (PDF)

The impact of first year adherence to antiretroviral therapy on long‐term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe

Tropical medicine & international health, 2012-05, Vol.17 (5), p.584-594

2012

Volltextzugriff (PDF)

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

PloS one, 2013, Vol.8 (2), p.e57580-e57580

2013

Volltextzugriff (PDF)

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Antiviral therapy, 2012-01, Vol.17 (7), p.1363-1373

2012

Volltextzugriff (PDF)

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4575-4580

2011

Volltextzugriff (PDF)

Long-Term Survivors in Nairobi: Complete HIV-1 RNA sequences and immunogenetic associations

The Journal of infectious diseases, 2004-08, Vol.190 (4), p.697-701

2004

Volltextzugriff (PDF)

Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors

Immunology letters, 1999-03, Vol.66 (1), p.9-14

1999

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy

The price of adherence: qualitative findings from HIV positive individuals purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda

Difficulties in the prevention, diagnosis, and treatment of imported malaria

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting

Identification of preferential CD4+ T-cell targets for HIV infection in the cervix

IDF21-0662 Diabetes CarePak: Creating & testing a bundling solution to improve access to safe insulin administration in Kenya

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial

Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda

Prevalence and Virologic Consequences of Transmitted HIV-1 Drug Resistance in Uganda

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial

Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μl

Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART

The impact of first year adherence to antiretroviral therapy on long‐term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

Long-Term Survivors in Nairobi: Complete HIV-1 RNA sequences and immunogenetic associations

Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors

Suchergebnisse filtern